Product
TWB-103
2 clinical trials
2 indications
Indication
Donor Site ComplicationIndication
Diabetic Foot UlcerClinical trial
A Phase I/II Study to Evaluate the Safety and Efficacy of TWB-103 in Adult Patients With Split-Thickness Skin Graft Donor Site Wounds (DSW)Status: Completed, Estimated PCD: 2021-05-07
Clinical trial
A Pilot Phase I/II Study to Evaluate the Safety and Efficacy of TWB-103 in Treating Lower Limb Ulcers on Patients With Diabetes MellitusStatus: Completed, Estimated PCD: 2021-07-09